Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
HDFC Pharma and Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.11.33731244634227.9672
Domestic EquitiesDivis Laboratories Ltd.8.3443259046167.7841
Domestic EquitiesLupin Ltd.6.4024618274128.7370
Domestic EquitiesGlenmark Pharmaceuticals Ltd.6.0864628837122.3843
Domestic EquitiesMax Healthcare Institute Limited6.06941049547122.0413
Domestic EquitiesAlkem Laboratories Ltd.5.8890208294118.4151
Domestic EquitiesIpca Laboratories Ltd.4.605263726092.6003
Domestic EquitiesLaurus Labs Ltd.4.017978334380.7901
Domestic EquitiesAnthem Biosciences Limited3.8911123272878.2412
Domestic EquitiesTorrent Pharmaceuticals Ltd.3.711720059874.6345
Domestic EquitiesAster DM Healthcare Limited3.5577107501571.5369
Domestic EquitiesKrishna Institute Of Medical Sciences Limited3.354998467667.4602
Domestic EquitiesAcutaas Chemicals Limited2.970032501059.7206
Domestic EquitiesCipla Ltd.2.885137884358.0122
Domestic EquitiesEris Lifesciences Ltd2.826035617356.8238
Domestic EquitiesMetropolis Healthcare Ltd.2.360324578247.4605
Domestic EquitiesVijaya Diagnostic Centre Limited2.303546409346.3188
Domestic EquitiesDr. Lal Path Labs Ltd1.790711798436.0064
Domestic EquitiesJubilant Pharmova Limited1.721031756834.6054
Domestic EquitiesThyrocare Technologies Ltd.1.649566911133.1678
Domestic EquitiesSai Life Sciences Limited1.619036808732.5536
Domestic EquitiesWockhardt Ltd.1.586325827931.8975
Domestic EquitiesAjanta Pharma Limited1.322210382026.5862
Domestic EquitiesPfizer Ltd.1.20144855624.1566
Domestic EquitiesGlobal Health Limited1.199019350024.1101
Domestic EquitiesShilpa Medicare Ltd1.164968592223.4242
Domestic EquitiesBAJAJ HEALTHCARE LIMITED1.128252456222.6847
Domestic EquitiesGland Pharma Ltd.1.095712521122.0321
Domestic EquitiesRubicon Research Limited1.034731722020.8049
Domestic EquitiesLaxmi Dental Limited0.887964443417.8540
Domestic EquitiesPiramal Pharma Limited0.36813953197.4008
Total 98.3806 1978.2124
Cash & Cash Equivalents and Net AssetsTREPS - Tri-party Repo1.5194 30.5522
Cash & Cash Equivalents and Net AssetsNet Current Assets0.1000 2.0099
Total 1.6194 32.5621
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.